Successful treatment of relapsed acute B-cell lymphoblastic leukemia with CD20/CD22 bispecific chimeric antigen receptor T-cell therapy

Regen Ther. 2020 Nov 25:15:281-284. doi: 10.1016/j.reth.2020.11.001. eCollection 2020 Dec.

Zuyu Liang^{1

2}, Jiazhen Cui^{1

2}, Alex Hongsheng Chang³, Jian Yu^{1

4}, Yongxian Hu^{1

4}, He Huang^{1

4}

¹ Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310003, China.
² Hematology institute of Zhejiang University, Hangzhou, 310003, China.
³ Clinical Translational Research Center, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
⁴ Hematology Institute of Zhejiang University, Hangzhou, 310003, China.

No abstract available

Keywords: Acute lymphoblastic leukemia; Bispecific chimeric antigen receptor T cells; CD19; CD20/CD22.